HEADER HYDROLASE 22-SEP-03 1UOQ TITLE PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND TITLE 2 PEPTIDE LIGAND GLU-PHE-SER-PRO COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROLYL ENDOPEPTIDASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: POST-PROLINE CLEAVING ENZYME, PE, PREP; COMPND 5 EC: 3.4.21.26; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: ENGINEERED MUTATION SER 554 ALA; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PEPTIDE LIGAND GLU-PHE-SER-PRO; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 TISSUE: BRAIN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS HYDROLASE, PROLYL OLIGOPEPTIDASE, AMNESIA, ALPHA/ BETA-HYDROLASE, KEYWDS 2 BETA-PROPELLER, SERINE PROTEASE EXPDTA X-RAY DIFFRACTION AUTHOR D.REA,V.FULOP REVDAT 5 13-DEC-23 1UOQ 1 REMARK REVDAT 4 08-FEB-17 1UOQ 1 SOURCE REMARK VERSN HETSYN REVDAT 4 2 1 FORMUL REVDAT 3 24-FEB-09 1UOQ 1 VERSN REVDAT 2 04-DEC-03 1UOQ 1 JRNL REVDAT 1 02-OCT-03 1UOQ 0 JRNL AUTH Z.SZELTNER,D.REA,V.RENNER,L.JULIANO,V.FULOP,L.POLGAR JRNL TITL ELECTROSTATIC ENVIRONMENT AT THE ACTIVE SITE OF PROLYL JRNL TITL 2 OLIGOPEPTIDASE IS HIGHLY INFLUENTIAL DURING SUBSTRATE JRNL TITL 3 BINDING JRNL REF J.BIOL.CHEM. V. 278 48786 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 14514675 JRNL DOI 10.1074/JBC.M309555200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Z.SZELTNER,D.REA,V.RENNER,V.FULOP,L.POLGAR REMARK 1 TITL ELECTROSTATIC EFFECTS AND BINDING DETERMINANTS IN THE REMARK 1 TITL 2 CATALYSIS OF PROLYL OLIGOPEPTIDASE: SITE SPECIFIC REMARK 1 TITL 3 MUTAGENESIS AT THE OXYANION BINDING SITE REMARK 1 REF J.BIOL.CHEM. V. 277 42613 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 12202494 REMARK 1 DOI 10.1074/JBC.M208043200 REMARK 1 REFERENCE 2 REMARK 1 AUTH Z.SZELTNER,D.REA,T.JUHASZ,V.RENNER,Z.MUCSI,G.OROSZ,V.FULOP, REMARK 1 AUTH 2 L.POLGAR REMARK 1 TITL SUBSTRATE-DEPENDENT COMPETENCY OF THE CATALYTIC TRIAD OF REMARK 1 TITL 2 PROLYL OLIGOPEPTIDASE REMARK 1 REF J.BIOL.CHEM. V. 277 44597 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 12228249 REMARK 1 DOI 10.1074/JBC.M207386200 REMARK 1 REFERENCE 3 REMARK 1 AUTH V.FULOP,Z.SZELTNER,V.RENNER,L.POLGAR REMARK 1 TITL STRUCTURES OF PROLYL OLIGOPEPTIDASE SUBSTRATE/ INHIBITOR REMARK 1 TITL 2 COMPLEXES. USE OF INHIBITOR BINDING FOR TITRATION OF THE REMARK 1 TITL 3 CATALYTIC HISTIDINE RESIDUE REMARK 1 REF J.BIOL.CHEM. V. 276 1262 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 11031266 REMARK 1 DOI 10.1074/JBC.M007003200 REMARK 1 REFERENCE 4 REMARK 1 AUTH V.FULOP,Z.SZELTNER,L.POLGAR REMARK 1 TITL CATALYSIS OF SERINE OLIGOPEPTIDASES IS CONTROLLED BY A REMARK 1 TITL 2 GATING FILTER MECHANISM REMARK 1 REF EMBO REP. V. 1 277 2000 REMARK 1 REFN ISSN 1469-221X REMARK 1 PMID 11256612 REMARK 1 DOI 10.1093/EMBO-REPORTS/KVD048 REMARK 1 REFERENCE 5 REMARK 1 AUTH V.FULOP,Z.BOCSKEI REMARK 1 TITL PROLYL OLIGOPEPTIDASE: AN UNUSUAL BETA-PROPELLER DOMAIN REMARK 1 TITL 2 REGULATES PROTEOLYSIS REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 94 161 1998 REMARK 1 REFN ISSN 0092-8674 REMARK 1 PMID 9695945 REMARK 1 DOI 10.1016/S0092-8674(00)81416-6 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 41394 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1827 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5734 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 532 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.72000 REMARK 3 B22 (A**2) : -1.67000 REMARK 3 B33 (A**2) : 0.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.197 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.173 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.100 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.663 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UOQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1290013561. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43221 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 36.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.12900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 1H2Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SEE REFERENCE 5, PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.15000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.90000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.55000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.90000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.15000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.55000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE DIMERIC ASSEMBLY DESCRIBED HERE IS DUE REMARK 300 TO A COMPLEXOF THE PROTEIN CHAIN A WITH A REMARK 300 PEPTIDE (CHAIN B). CHAIN AIS ESSENTIALLY A MONOMER REMARK 300 IN THE PHYSIOLOGICAL STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED MUTATION IN CHAIN A, SER 554 ALA REMARK 400 THE MUTATED REGION CORREPONDS TO THE ACT_SITE CHARGE RELAY REMARK 400 OF THE SEQUENCE REMARK 400 REMARK 400 CLEAVES PEPTIDE BONDS ON THE C-TERMINAL SIDE OF PROLYL REMARK 400 RESIDUES WITHIN PEPTIDES OF UP TO APPROXIMATELY 30 AMINO REMARK 400 ACIDS IN LENGTH. BELONGS TO PEPTIDASE FAMILY S9A. REMARK 400 REMARK 400 CATALYTIC ACTIVITY: HYDROLYSIS OF PRO-|-XAA >> ALA-|-XAA IN REMARK 400 OLIGOPEPTIDES. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2136 O HOH A 2417 3656 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 18 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 CYS A 57 CA - CB - SG ANGL. DEV. = -11.1 DEGREES REMARK 500 ASP A 104 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP A 242 CB - CG - OD2 ANGL. DEV. = 7.4 DEGREES REMARK 500 ASP A 291 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 LEU A 351 CB - CG - CD2 ANGL. DEV. = 11.7 DEGREES REMARK 500 ASP A 463 CB - CG - OD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP A 642 CB - CG - OD1 ANGL. DEV. = 6.6 DEGREES REMARK 500 ASP A 695 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 306 107.13 -57.01 REMARK 500 SER A 308 80.64 -150.31 REMARK 500 TYR A 311 150.00 74.32 REMARK 500 LYS A 335 -41.00 -138.50 REMARK 500 SER A 346 -63.05 63.65 REMARK 500 GLU A 378 -177.91 -66.40 REMARK 500 TYR A 473 -75.95 -127.18 REMARK 500 LEU A 520 -121.78 59.05 REMARK 500 ALA A 554 -111.07 66.95 REMARK 500 THR A 590 -106.28 23.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 405 ILE A 406 145.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1711 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1712 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E5T RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT REMARK 900 RELATED ID: 1E8M RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1E8N RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1H2W RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN REMARK 900 RELATED ID: 1H2X RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y473F MUTANT REMARK 900 RELATED ID: 1H2Y RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, Y473F MUTANT WITH REMARK 900 COVALENTLY BOUND INHIBITOR Z-PRO-PROLINAL REMARK 900 RELATED ID: 1H2Z RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND REMARK 900 PEPTIDE LIGAND SUC- GLY-PRO REMARK 900 RELATED ID: 1O6F RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641A MUTANT WITH BOUND REMARK 900 PEPTIDE LIGAND SUC- GLY-PRO REMARK 900 RELATED ID: 1O6G RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641N MUTANT WITH BOUND REMARK 900 PEPTIDE LIGAND SUC- GLY-PRO REMARK 900 RELATED ID: 1QFM RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE MUSCLE REMARK 900 RELATED ID: 1QFS RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE MUSCLE WITH COVALENTLY BOUND REMARK 900 INHIBITOR Z-PRO-PROLINAL REMARK 900 RELATED ID: 1UOO RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND REMARK 900 PEPTIDE LIGAND GLY-PHE-ARG-PRO REMARK 900 RELATED ID: 1UOP RELATED DB: PDB REMARK 900 PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, S554A MUTANT WITH BOUND REMARK 900 PEPTIDE LIGAND GLY-PHE-GLU-PRO DBREF 1UOQ A 1 710 UNP P23687 PPCE_PIG 1 710 DBREF 1UOQ B 723 726 PDB 1UOQ 1UOQ 723 726 SEQADV 1UOQ ALA A 554 UNP P23687 SER 554 ENGINEERED MUTATION SEQRES 1 A 710 MET LEU SER PHE GLN TYR PRO ASP VAL TYR ARG ASP GLU SEQRES 2 A 710 THR ALA ILE GLN ASP TYR HIS GLY HIS LYS VAL CYS ASP SEQRES 3 A 710 PRO TYR ALA TRP LEU GLU ASP PRO ASP SER GLU GLN THR SEQRES 4 A 710 LYS ALA PHE VAL GLU ALA GLN ASN LYS ILE THR VAL PRO SEQRES 5 A 710 PHE LEU GLU GLN CYS PRO ILE ARG GLY LEU TYR LYS GLU SEQRES 6 A 710 ARG MET THR GLU LEU TYR ASP TYR PRO LYS TYR SER CYS SEQRES 7 A 710 HIS PHE LYS LYS GLY LYS ARG TYR PHE TYR PHE TYR ASN SEQRES 8 A 710 THR GLY LEU GLN ASN GLN ARG VAL LEU TYR VAL GLN ASP SEQRES 9 A 710 SER LEU GLU GLY GLU ALA ARG VAL PHE LEU ASP PRO ASN SEQRES 10 A 710 ILE LEU SER ASP ASP GLY THR VAL ALA LEU ARG GLY TYR SEQRES 11 A 710 ALA PHE SER GLU ASP GLY GLU TYR PHE ALA TYR GLY LEU SEQRES 12 A 710 SER ALA SER GLY SER ASP TRP VAL THR ILE LYS PHE MET SEQRES 13 A 710 LYS VAL ASP GLY ALA LYS GLU LEU PRO ASP VAL LEU GLU SEQRES 14 A 710 ARG VAL LYS PHE SER CYS MET ALA TRP THR HIS ASP GLY SEQRES 15 A 710 LYS GLY MET PHE TYR ASN ALA TYR PRO GLN GLN ASP GLY SEQRES 16 A 710 LYS SER ASP GLY THR GLU THR SER THR ASN LEU HIS GLN SEQRES 17 A 710 LYS LEU TYR TYR HIS VAL LEU GLY THR ASP GLN SER GLU SEQRES 18 A 710 ASP ILE LEU CYS ALA GLU PHE PRO ASP GLU PRO LYS TRP SEQRES 19 A 710 MET GLY GLY ALA GLU LEU SER ASP ASP GLY ARG TYR VAL SEQRES 20 A 710 LEU LEU SER ILE ARG GLU GLY CYS ASP PRO VAL ASN ARG SEQRES 21 A 710 LEU TRP TYR CYS ASP LEU GLN GLN GLU SER ASN GLY ILE SEQRES 22 A 710 THR GLY ILE LEU LYS TRP VAL LYS LEU ILE ASP ASN PHE SEQRES 23 A 710 GLU GLY GLU TYR ASP TYR VAL THR ASN GLU GLY THR VAL SEQRES 24 A 710 PHE THR PHE LYS THR ASN ARG HIS SER PRO ASN TYR ARG SEQRES 25 A 710 LEU ILE ASN ILE ASP PHE THR ASP PRO GLU GLU SER LYS SEQRES 26 A 710 TRP LYS VAL LEU VAL PRO GLU HIS GLU LYS ASP VAL LEU SEQRES 27 A 710 GLU TRP VAL ALA CYS VAL ARG SER ASN PHE LEU VAL LEU SEQRES 28 A 710 CYS TYR LEU HIS ASP VAL LYS ASN THR LEU GLN LEU HIS SEQRES 29 A 710 ASP LEU ALA THR GLY ALA LEU LEU LYS ILE PHE PRO LEU SEQRES 30 A 710 GLU VAL GLY SER VAL VAL GLY TYR SER GLY GLN LYS LYS SEQRES 31 A 710 ASP THR GLU ILE PHE TYR GLN PHE THR SER PHE LEU SER SEQRES 32 A 710 PRO GLY ILE ILE TYR HIS CYS ASP LEU THR LYS GLU GLU SEQRES 33 A 710 LEU GLU PRO ARG VAL PHE ARG GLU VAL THR VAL LYS GLY SEQRES 34 A 710 ILE ASP ALA SER ASP TYR GLN THR VAL GLN ILE PHE TYR SEQRES 35 A 710 PRO SER LYS ASP GLY THR LYS ILE PRO MET PHE ILE VAL SEQRES 36 A 710 HIS LYS LYS GLY ILE LYS LEU ASP GLY SER HIS PRO ALA SEQRES 37 A 710 PHE LEU TYR GLY TYR GLY GLY PHE ASN ILE SER ILE THR SEQRES 38 A 710 PRO ASN TYR SER VAL SER ARG LEU ILE PHE VAL ARG HIS SEQRES 39 A 710 MET GLY GLY VAL LEU ALA VAL ALA ASN ILE ARG GLY GLY SEQRES 40 A 710 GLY GLU TYR GLY GLU THR TRP HIS LYS GLY GLY ILE LEU SEQRES 41 A 710 ALA ASN LYS GLN ASN CYS PHE ASP ASP PHE GLN CYS ALA SEQRES 42 A 710 ALA GLU TYR LEU ILE LYS GLU GLY TYR THR SER PRO LYS SEQRES 43 A 710 ARG LEU THR ILE ASN GLY GLY ALA ASN GLY GLY LEU LEU SEQRES 44 A 710 VAL ALA THR CYS ALA ASN GLN ARG PRO ASP LEU PHE GLY SEQRES 45 A 710 CYS VAL ILE ALA GLN VAL GLY VAL MET ASP MET LEU LYS SEQRES 46 A 710 PHE HIS LYS TYR THR ILE GLY HIS ALA TRP THR THR ASP SEQRES 47 A 710 TYR GLY CYS SER ASP SER LYS GLN HIS PHE GLU TRP LEU SEQRES 48 A 710 ILE LYS TYR SER PRO LEU HIS ASN VAL LYS LEU PRO GLU SEQRES 49 A 710 ALA ASP ASP ILE GLN TYR PRO SER MET LEU LEU LEU THR SEQRES 50 A 710 ALA ASP HIS ASP ASP ARG VAL VAL PRO LEU HIS SER LEU SEQRES 51 A 710 LYS PHE ILE ALA THR LEU GLN TYR ILE VAL GLY ARG SER SEQRES 52 A 710 ARG LYS GLN ASN ASN PRO LEU LEU ILE HIS VAL ASP THR SEQRES 53 A 710 LYS ALA GLY HIS GLY ALA GLY LYS PRO THR ALA LYS VAL SEQRES 54 A 710 ILE GLU GLU VAL SER ASP MET PHE ALA PHE ILE ALA ARG SEQRES 55 A 710 CYS LEU ASN ILE ASP TRP ILE PRO SEQRES 1 B 4 GLU PHE SER PRO HET GOL A1711 6 HET GOL A1712 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 HOH *532(H2 O) HELIX 1 1 TYR A 28 ASP A 33 5 6 HELIX 2 2 SER A 36 GLN A 56 1 21 HELIX 3 3 PRO A 58 ASP A 72 1 15 HELIX 4 4 ASP A 115 SER A 120 5 6 HELIX 5 5 ASP A 218 ASP A 222 5 5 HELIX 6 6 GLN A 267 GLU A 269 5 3 HELIX 7 7 GLU A 322 TRP A 326 5 5 HELIX 8 8 ASP A 431 SER A 433 5 3 HELIX 9 9 SER A 485 GLY A 496 1 12 HELIX 10 10 TYR A 510 GLY A 517 1 8 HELIX 11 11 GLY A 518 ALA A 521 5 4 HELIX 12 12 ASN A 522 GLU A 540 1 19 HELIX 13 13 SER A 544 LYS A 546 5 3 HELIX 14 14 ALA A 554 ARG A 567 1 14 HELIX 15 15 PRO A 568 PHE A 571 5 4 HELIX 16 16 LYS A 585 TYR A 589 5 5 HELIX 17 17 ILE A 591 ALA A 594 5 4 HELIX 18 18 TRP A 595 GLY A 600 1 6 HELIX 19 19 SER A 604 SER A 615 1 12 HELIX 20 20 PRO A 616 ASN A 619 5 4 HELIX 21 21 PRO A 646 VAL A 660 1 15 HELIX 22 22 PRO A 685 ASN A 705 1 21 SHEET 1 AA 2 ILE A 16 TYR A 19 0 SHEET 2 AA 2 HIS A 22 CYS A 25 -1 O HIS A 22 N TYR A 19 SHEET 1 AB 3 LYS A 75 TYR A 76 0 SHEET 2 AB 3 ARG A 85 ASN A 91 -1 O ASN A 91 N LYS A 75 SHEET 3 AB 3 PHE A 80 LYS A 82 -1 O PHE A 80 N PHE A 87 SHEET 1 AC 4 LYS A 75 TYR A 76 0 SHEET 2 AC 4 ARG A 85 ASN A 91 -1 O ASN A 91 N LYS A 75 SHEET 3 AC 4 VAL A 99 GLN A 103 -1 O VAL A 99 N TYR A 90 SHEET 4 AC 4 ARG A 111 LEU A 114 -1 O ARG A 111 N VAL A 102 SHEET 1 AD 4 VAL A 125 PHE A 132 0 SHEET 2 AD 4 TYR A 138 ALA A 145 -1 O ALA A 140 N ALA A 131 SHEET 3 AD 4 VAL A 151 LYS A 157 -1 O THR A 152 N LEU A 143 SHEET 4 AD 4 LYS A 162 VAL A 171 -1 O LYS A 162 N LYS A 157 SHEET 1 AE 4 ALA A 177 TRP A 178 0 SHEET 2 AE 4 GLY A 184 ALA A 189 -1 O PHE A 186 N ALA A 177 SHEET 3 AE 4 LYS A 209 VAL A 214 -1 O LYS A 209 N ALA A 189 SHEET 4 AE 4 ILE A 223 ALA A 226 -1 O ILE A 223 N TYR A 212 SHEET 1 AF 4 MET A 235 LEU A 240 0 SHEET 2 AF 4 TYR A 246 ARG A 252 -1 O LEU A 248 N GLU A 239 SHEET 3 AF 4 ARG A 260 ASP A 265 -1 O ARG A 260 N ILE A 251 SHEET 4 AF 4 VAL A 280 ILE A 283 -1 O VAL A 280 N TYR A 263 SHEET 1 AG 4 TYR A 290 GLU A 296 0 SHEET 2 AG 4 VAL A 299 THR A 304 -1 O VAL A 299 N GLU A 296 SHEET 3 AG 4 ARG A 312 ASP A 317 -1 O ARG A 312 N THR A 304 SHEET 4 AG 4 LYS A 327 VAL A 330 -1 O LYS A 327 N ASN A 315 SHEET 1 AH 4 VAL A 337 VAL A 344 0 SHEET 2 AH 4 PHE A 348 HIS A 355 -1 O PHE A 348 N VAL A 344 SHEET 3 AH 4 LYS A 358 ASP A 365 -1 O LYS A 358 N HIS A 355 SHEET 4 AH 4 LEU A 371 PHE A 375 -1 N LEU A 372 O LEU A 363 SHEET 1 AI 4 SER A 381 SER A 386 0 SHEET 2 AI 4 GLU A 393 THR A 399 -1 O PHE A 395 N SER A 386 SHEET 3 AI 4 ILE A 406 ASP A 411 -1 O ILE A 406 N PHE A 398 SHEET 4 AI 4 ARG A 420 GLU A 424 -1 O ARG A 420 N HIS A 409 SHEET 1 AJ 8 TYR A 435 PRO A 443 0 SHEET 2 AJ 8 LYS A 449 LYS A 457 -1 O ILE A 450 N TYR A 442 SHEET 3 AJ 8 VAL A 498 ALA A 502 -1 O LEU A 499 N VAL A 455 SHEET 4 AJ 8 ALA A 468 TYR A 471 1 O PHE A 469 N ALA A 500 SHEET 5 AJ 8 LEU A 548 GLY A 553 1 O THR A 549 N LEU A 470 SHEET 6 AJ 8 CYS A 573 GLN A 577 1 O CYS A 573 N ILE A 550 SHEET 7 AJ 8 SER A 632 ALA A 638 1 O SER A 632 N VAL A 574 SHEET 8 AJ 8 LEU A 670 ASP A 675 1 O LEU A 671 N LEU A 635 SITE 1 AC1 7 ILE A 118 LEU A 119 SER A 120 ASP A 121 SITE 2 AC1 7 ASP A 446 ASN A 522 ASN A 525 SITE 1 AC2 7 ALA A 226 GLU A 227 PHE A 228 TRP A 262 SITE 2 AC2 7 ILE A 276 LYS A 281 HOH A2530 CRYST1 70.300 99.100 109.800 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014225 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010091 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009107 0.00000